Kinetic Insights with AssayQuant’s Fully Automated KinSight™ Kinome Profiling Services
MARLBOROUGH, Mass., June 21, 2023 /PRNewswire/ — AssayQuant® Technologies, Inc. introduces KinSight™ Kinome Profiling Services providing superior results including kinetic insights into selectivity and mechanisms of action for drug discovery. Kinase inhibitors are effective in targeting deregulation mechanisms that drive disease progression, yet only 15% of kinases have FDA-approved inhibitors. AssayQuant’s kinome profiling platform provides … Read more